tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Sellas Life Sciences Group Inc

SLS
Add to Watchlist
10.000USD
-0.290-2.82%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.81BMarket Cap
LossP/E TTM

Sellas Life Sciences Group Inc

10.000
-0.290-2.82%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

SLS Financials

See Sellas Life Sciences Group Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Sellas Life Sciences Group Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.05/-0.04
Revenue / Forecast
--/--
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.25
51.18%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
26.42%-0.05
40.47%-0.05
39.84%-0.06
48.33%-0.07
68.97%-0.07
65.52%-0.09
68.14%-0.10
58.43%-0.13
54.70%-0.21
39.81%-0.26
---0.33
---0.31
---0.47
---0.44
---1.70
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
-100.00%0.00
-82.46%1.00M
-100.00%0.00
--0.00
--1.90M
Net Profit
-44.62%-8.41M
-13.67%-7.66M
4.46%-6.79M
11.63%-6.60M
39.23%-5.81M
17.20%-6.74M
23.30%-7.11M
15.50%-7.47M
13.80%-9.57M
10.80%-8.14M
-31.97%-9.27M
-5.06%-8.84M
33.73%-11.10M
-38.24%-9.12M
0.89%-7.02M
-82.40%-8.41M
-596.80%-16.74M
-77.56%-6.60M
-58.39%-7.08M
-4.25%-4.61M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---3218.00%
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--90.00%
----
----
----
----
----
Income Statement
Revenue
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
-100.00%0.00
-82.46%1.00M
-100.00%0.00
--0.00
--1.90M
Operating profit
-52.60%-9.25M
-19.33%-8.26M
3.36%-7.08M
9.81%-6.87M
37.14%-6.06M
15.40%-6.92M
21.71%-7.33M
15.79%-7.62M
14.50%-9.64M
13.43%-8.18M
-31.00%-9.36M
-4.95%-9.05M
-67.50%-11.28M
-59.59%-9.45M
-2.42%-7.15M
-93.64%-8.62M
-200.00%-6.74M
-42.32%-5.92M
-55.32%-6.98M
-4.36%-4.45M
Net Profit
-44.62%-8.41M
-13.67%-7.66M
4.46%-6.79M
11.63%-6.60M
39.23%-5.81M
17.20%-6.74M
23.30%-7.11M
15.50%-7.47M
13.80%-9.57M
10.80%-8.14M
-31.97%-9.27M
-5.06%-8.84M
33.73%-11.10M
-38.24%-9.12M
0.89%-7.02M
-82.40%-8.41M
-596.80%-16.74M
-77.56%-6.60M
-58.39%-7.08M
-4.25%-4.61M
Balance Sheet
Current assets
247.70%111.17M
360.65%75.21M
104.08%49.05M
139.37%29.45M
48.70%31.97M
414.72%16.33M
361.95%24.04M
-21.04%12.30M
-17.37%21.50M
-82.14%3.17M
-76.98%5.20M
-45.78%15.58M
45.87%26.02M
-22.95%17.76M
-21.98%22.61M
-16.89%28.74M
-43.24%17.84M
-37.59%23.04M
210.45%28.97M
561.22%34.58M
Total current liabilities
-6.27%6.46M
-26.21%7.02M
-44.17%5.92M
-50.20%6.00M
-52.29%6.89M
-30.76%9.51M
-9.56%10.61M
-10.25%12.04M
-6.92%14.44M
-11.47%13.73M
-6.52%11.73M
10.13%13.42M
45.25%15.51M
211.42%15.52M
136.00%12.55M
187.47%12.19M
78.85%10.68M
-59.61%4.98M
26.07%5.32M
-1.99%4.24M
Total assets
226.63%114.18M
303.18%78.34M
94.51%51.55M
113.67%32.30M
43.06%34.96M
212.46%19.43M
227.79%26.50M
-18.57%15.12M
-16.05%24.43M
-70.31%6.22M
-68.90%8.09M
-42.36%18.57M
35.78%29.10M
-20.29%20.94M
-31.49%26.00M
-26.16%32.21M
-47.17%21.43M
-42.94%26.27M
105.05%37.95M
200.56%43.62M
Total liabilities
-6.00%6.76M
-25.01%7.47M
-44.17%5.92M
-49.57%6.16M
-51.21%7.20M
-29.79%9.97M
-10.91%10.61M
-11.05%12.21M
-7.44%14.75M
-11.79%14.20M
-11.12%11.91M
4.33%13.72M
-8.47%15.94M
171.46%16.09M
18.15%13.40M
28.84%13.15M
47.12%17.41M
-67.23%5.93M
7.42%11.35M
-4.86%10.21M
Total equity
286.94%107.41M
648.77%70.87M
187.13%45.63M
797.67%26.15M
186.65%27.76M
218.67%9.46M
515.26%15.89M
-39.85%2.91M
-26.46%9.68M
-264.42%-7.98M
-130.38%-3.83M
-74.59%4.84M
227.18%13.17M
-76.16%4.85M
-52.66%12.60M
-42.97%19.06M
-86.00%4.03M
-27.23%20.35M
234.76%26.61M
783.29%33.41M
Cash Flow Statement
Net operating income
2.47%-8.85M
31.20%-4.92M
9.45%-7.07M
24.29%-7.33M
15.71%-9.07M
-48.25%-7.15M
-13.26%-7.81M
-27.97%-9.68M
11.26%-10.76M
6.35%-4.83M
-19.94%-6.89M
-31.33%-7.57M
-69.61%-12.13M
-3.54%-5.15M
2.25%-5.75M
-17.62%-5.76M
30.37%-7.15M
-245.33%-4.98M
-61.97%-5.88M
-44.87%-4.90M
Net investment
----
----
----
----
----
--0.00
100.00%0.00
----
----
--0.00
---3.00M
44.44%-2.50M
----
--0.00
--0.00
---4.50M
----
----
----
----
Net financing
87.23%44.15M
404825.00%32.39M
32.51%26.09M
921.74%4.23M
-11.50%23.58M
-99.76%8.00K
36362.96%19.69M
1527.59%414.00K
40.95%26.65M
264.48%3.39M
-49.53%54.00K
-100.13%-29.00K
40121.28%18.90M
1758.00%929.00K
-95.23%107.00K
239.07%23.00M
-98.43%47.00K
-99.79%50.00K
-73.60%2.24M
27228.00%6.78M

FAQs

What are the current assets of Sellas Life Sciences Group Inc?

According to Sellas Life Sciences Group Inc's FY2025 earnings report, its current assets were 75.21M, with a year-on-year change of 360.65.

What are the total assets of Sellas Life Sciences Group Inc?

According to Sellas Life Sciences Group Inc's FY2025 earnings report, its total assets of Sellas Life Sciences Group Inc were 78.34M, with a year-on-year change of 303.18.

What are the total liabilities of Sellas Life Sciences Group Inc?

According to Sellas Life Sciences Group Inc's FY2025 earnings report, its total liabilities of Sellas Life Sciences Group Inc were 7.47M, with a year-on-year change of -25.01.

What is the total equity of Sellas Life Sciences Group Inc?

According to Sellas Life Sciences Group Inc's FY2025 earnings report, its total equity of Sellas Life Sciences Group Inc was 70.87M, with a year-on-year change of 648.77.

What is the net operating income of Sellas Life Sciences Group Inc?

According to Sellas Life Sciences Group Inc's FY2025 earnings report, its net operating income of Sellas Life Sciences Group Inc was -28.27M, with a year-on-year change of 10.28.

What is the net financing of Sellas Life Sciences Group Inc?

According to Sellas Life Sciences Group Inc's FY2025 earnings report, its net financing of Sellas Life Sciences Group Inc was 86.30M, with a year-on-year change of 84.56.

What is the Earnings Per Share (EPS) of Sellas Life Sciences Group Inc?

According to Sellas Life Sciences Group Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.25, with a year-on-year change of 51.18.

What is the net income of Sellas Life Sciences Group Inc?

According to Sellas Life Sciences Group Inc's FY2025 earnings report, its net income was -26.86M, with a year-on-year change of 13.01.

What is the Return on Equity (ROE) of Sellas Life Sciences Group Inc?

According to Sellas Life Sciences Group Inc's FY2025 earnings report, its Return on Equity (ROE) was -66.88, with a year-on-year change of 98.39.

What is the Return on Assets (ROA) of Sellas Life Sciences Group Inc?

According to Sellas Life Sciences Group Inc's FY2025 earnings report, its Return on Assets (ROA) was -54.95, with a year-on-year change of 77.18.

What is the operating profit of Sellas Life Sciences Group Inc?

According to Sellas Life Sciences Group Inc's FY2025 earnings report, its operating profit was -28.27M, with a year-on-year change of 10.28.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy